We now offer an alternate form of treatment for actinic keratoses called photodynamic blue light therapy.

LEVULAN KERASTICK + BLU-U was designed to target AKs where they exist in the epidermis without unnecessary exposure to deeper tissue.

LEVULAN KERASTICK + BLU-U has been approved to treat minimally to moderately thick AKs of the face or scalp since 1999, and as of 2018, AKs on the upper extremities. It is a dual-mechanism PDT that utilizes the power of 20% ALA, a porphyrin precursor present in LEVULAN KERASTICK, and the precision of the BLU-U blue-light source, which is used to activate the topical solution.

To learn more on the Levulan website, please click the button below.